Language

News topic

Active ingredient Doxorubicin Hydrochloride

Current shortage notices for the active ingredient Doxorubicin Hydrochloride, structured by product, country and reporting period.

5 notices

← All shortages

What the Doxorubicin Hydrochloride notices indicate for the supply chain

The 5 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Doxorubicin Accord Healthcare 2 mg/ml inf. sol. (conc.) i.v. vial 100 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 25 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 10 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 25 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →
Belgium

Caelyx Pegylated Liposomal 2 mg/ml inf. opl. (conc.) i.v. flac. 25 ml

Active ingredient: Doxorubicin Hydrochloride

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.